465 related articles for article (PubMed ID: 24744575)
1. Colorectal cancer screening: 20 years of development and recent progress.
Zavoral M; Suchanek S; Majek O; Fric P; Minarikova P; Minarik M; Seifert B; Dusek L
World J Gastroenterol; 2014 Apr; 20(14):3825-34. PubMed ID: 24744575
[TBL] [Abstract][Full Text] [Related]
2. [Population colorectal cancer screening in the Czech Republic].
Zavoral M; Vojtěchová G; Májek O; Ngo O; Grega T; Seifert B; Dušek L; Suchánek Š
Cas Lek Cesk; 2016; 155(1):7-12. PubMed ID: 26898786
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening in Europe.
Zavoral M; Suchanek S; Zavada F; Dusek L; Muzik J; Seifert B; Fric P
World J Gastroenterol; 2009 Dec; 15(47):5907-15. PubMed ID: 20014454
[TBL] [Abstract][Full Text] [Related]
4. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
5. [Results of the Czech National Colorectal Cancer screening programme - faecal occult blood tests].
Seifert B; Májek O; Zavoral M; Král N; Suchánek S; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():87-97. PubMed ID: 25494893
[TBL] [Abstract][Full Text] [Related]
6. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
7. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
8. [Results of the Czech National Colorectal Cancer Screening Programme - colonoscopy examinations].
Suchánek S; Májek O; Zavoral M; Seifert B; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():98-105. PubMed ID: 25494894
[TBL] [Abstract][Full Text] [Related]
9. The impact of stratifying by family history in colorectal cancer screening programs.
Goede SL; Rabeneck L; Lansdorp-Vogelaar I; Zauber AG; Paszat LF; Hoch JS; Yong JH; van Hees F; Tinmouth J; van Ballegooijen M
Int J Cancer; 2015 Sep; 137(5):1119-27. PubMed ID: 25663135
[TBL] [Abstract][Full Text] [Related]
10. [The populations attitudes to colorectal cancer screening in the Czech Republic].
Král N; Seifert B; Suchánek Š; Zavoral M; Májek O
Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):41-6. PubMed ID: 25872995
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Screening Using Fecal Occult Blood Testing and Colonoscopy on the Risk of Colorectal Cancer: The Japan Public Health Center-based Prospective Study.
Tanaka K; Sobue T; Zha L; Kitamura T; Sawada N; Iwasaki M; Inoue M; Yamaji T; Tsugane S
J Epidemiol; 2023 Feb; 33(2):91-100. PubMed ID: 34053963
[TBL] [Abstract][Full Text] [Related]
12. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests.
Meklin J; Syrjänen K; Eskelinen M
Anticancer Res; 2020 Feb; 40(2):575-581. PubMed ID: 32014898
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
15. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening in the Czech Republic.
Zavoral M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S29-30. PubMed ID: 18368637
[TBL] [Abstract][Full Text] [Related]
17. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
18. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
Daniels K; McKee M
J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
[TBL] [Abstract][Full Text] [Related]
19. Fecal Occult Blood Test Results of the National Colorectal Cancer Screening Program in South Korea (2006-2013).
Rim JH; Youk T; Kang JG; Park BK; Gee HY; Kim JH; Yoo J
Sci Rep; 2017 Jun; 7(1):2804. PubMed ID: 28584248
[TBL] [Abstract][Full Text] [Related]
20. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.
Ribbing Wilén H; Saraste D; Blom J
J Med Screen; 2022 Sep; 29(3):156-165. PubMed ID: 35257615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
